Skin disease related to metabolic syndrome in women.

Abstract

Sex hormones are involved in pathways of metabolic syndrome (MetS), an observation supported by animal studies. The relationships of sex hormones with components of MetS, such as insulin resistance and dyslipidemia, have been studied in pre- and postmenopausal women. High testosterone, low sex hormone-binding globulin, and low estrogen levels increase the risks of MetS and type 2 diabetes in women. Cutaneous diseases that are sex hormone mediated, such as polycystic ovary syndrome, acanthosis nigricans, acne vulgaris, and pattern alopecia, have been associated with insulin resistance and increased risk for MetS. Furthermore, inflammatory skin conditions, such as hidradenitis suppurativa and psoriasis, increase the risk for MetS. Patients with such skin conditions should be followed for metabolic complications, and early lifestyle interventions toward these populations may be warranted.

• Authors: Angelica Misitzis, Paulo R Cunha, George Kroumpouzos
• Journal: International journal of women's dermatology (Int J Womens Dermatol) Vol. 5 Issue 4 Pg. 205-212 (Sep 2019) ISSN: 2352-6475 [Print] United States
• PMID: 31700973 (Publication Type: Journal Article, Review)
• Copyright: © 2019 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.